Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas
Open Access
- 1 September 2011
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 24 (9), 1237-1247
- https://doi.org/10.1038/modpathol.2011.74
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Pancreatic Cancers Epigenetically Silence SIP1 and Hypomethylate and Overexpress miR-200a/200b in Association with Elevated Circulating miR-200a and miR-200b LevelsCancer Research, 2010
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic CancerClinical Cancer Research, 2009
- The basics of epithelial-mesenchymal transitionJCI Insight, 2009
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic CancerJournal of Clinical Oncology, 2009
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling PathwayCancer Research, 2009
- Cadherins and cancer: how does cadherin dysfunction promote tumor progression?Oncogene, 2008
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2Journal of Biological Chemistry, 2008
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Genes & Development, 2008
- CpG island methylation profile of pancreatic intraepithelial neoplasiaLaboratory Investigation, 2007